StockData
enGene Therapeutics Inc. logo

enGene Therapeutics Inc. (ENGN) dividend history

ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30
$1.72−0.17 (-8.99%)

Close on Nov 17, 2026Market cap $115.27MP/E –Yield 0.00%

Dividends

enGene Therapeutics has not reported a dividend

No dividend per share appears in enGene Therapeutics's annual filings since fiscal 2021.

See a number that looks wrong?